Strongbridge Biopharma plc - Ordinary Shares (SBBP): Price and Financial Metrics


Strongbridge Biopharma plc - Ordinary Shares (SBBP)

Today's Latest Price: $3.42 USD

0.15 (-4.20%)

Updated May 29 4:00pm

Add SBBP to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 214 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

SBBP Stock Summary

  • The ratio of debt to operating expenses for Strongbridge Biopharma plc is higher than it is for about merely 0.34% of US stocks.
  • SBBP's price/sales ratio is 8.05; that's higher than the P/S ratio of 85.84% of US stocks.
  • In terms of twelve month growth in earnings before interest and taxes, Strongbridge Biopharma plc is reporting a growth rate of -180.43%; that's higher than merely 9.49% of US stocks.
  • If you're looking for stocks that are quantitatively similar to Strongbridge Biopharma plc, a group of peers worth examining would be RKDA, KIN, MRAM, CYRN, and EYES.
  • SBBP's SEC filings can be seen here. And to visit Strongbridge Biopharma plc's official web site, go to www.strongbridgebio.com.
SBBP Daily Price Range
SBBP 52-Week Price Range

SBBP Stock Price Chart More Charts


SBBP Price/Volume Stats

Current price $3.42 52-week high $3.89
Prev. close $3.57 52-week low $1.43
Day low $3.33 Volume 259,204
Day high $3.65 Avg. volume 413,114
50-day MA $2.50 Dividend yield N/A
200-day MA $2.39 Market Cap 185.53M

Strongbridge Biopharma plc - Ordinary Shares (SBBP) Company Bio


Strongbridge Biopharma PLC is focused on the development, in-licensing, acquisition and eventual commercialization of complementary product candidates across multiple franchises that target rare diseases. The company was founded in 1996 and is based in Trevose, Pennsylvania.


SBBP Latest News Stream


Event/TimeNews Detail
Loading, please wait...

SBBP Latest Social Stream


Loading social stream, please wait...

View Full SBBP Social Stream

Latest SBBP News From Around the Web

Below are the latest news stories about Strongbridge Biopharma plc that investors may wish to consider to help them evaluate SBBP as an investment opportunity.

We're Hopeful That Strongbridge Biopharma (NASDAQ:SBBP) Will Use Its Cash Wisely

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Yahoo | May 27, 2020

Strongbridge Biopharma plc Announces $30 Million Debt Facility with Avenue Venture Opportunities Fund, L.P.

Strongbridge Biopharma plc, (SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that it and its subsidiaries have entered into a $30 million debt facility with Avenue Venture Opportunities Fund, L.P. (Avenue), a fund within the Avenue Capital Group, and its affiliates. The debt facility also provides Strongbridge U.S. Inc., with two potential additional tranches of up to $10 million each.

Yahoo | May 20, 2020

2 Biotech Stocks Under $5 With Blockbuster Potential

A lot can change after a single trip around the sun. While COVID-19 has had a devastating impact on the economy, CFRA’s chief investment strategist, Sam Stovall, thinks that the market will continue to stage a recovery, with stocks returning to all-time highs in the next year.“In other bear markets going back to 1929, and the average 13-month advance was 50%. We have a very good possibility of retracing our steps and challenging the old high,” Stovall stated. He estimates that the S&P 500 will reach the 3,435 mark in the next twelve months, which from current levels, would reflect a 17% pop as well as surpass the 3,393 high-point hit back on February 19.That’s not to say the reopening of the economy won’t bring about a second wave of COVID-19 infections, but Stovall argues that even if ...

Yahoo | May 18, 2020

Strongbridge Biopharma plc to Present at Upcoming 2020 Solebury Trout Virtual Global Healthcare Conference Series

DUBLIN, Ireland and TREVOSE, Pa., May 18, 2020 -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and.

Yahoo | May 18, 2020

Edited Transcript of SBBP earnings conference call or presentation 6-May-20 12:30pm GMT

Q1 2020 Strongbridge Biopharma plc Earnings Call

Yahoo | May 15, 2020

Read More 'SBBP' Stories Here

SBBP Price Returns

1-mo 19.58%
3-mo 23.47%
6-mo 88.95%
1-year 17.53%
3-year -27.23%
5-year N/A
YTD 63.64%
2019 -53.35%
2018 -38.21%
2017 202.08%
2016 -68.42%
2015 N/A

Continue Researching SBBP

Here are a few links from around the web to help you further your research on Strongbridge Biopharma plc's stock as an investment opportunity:

Strongbridge Biopharma plc (SBBP) Stock Price | Nasdaq
Strongbridge Biopharma plc (SBBP) Stock Quote, History and News - Yahoo Finance
Strongbridge Biopharma plc (SBBP) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8021 seconds.